Protagonist Therapeutics: Much More Than Rusfertide In Place To Carry It
Protagonist Therapeutics, Inc.'s VERIFY and ANTHEM-UC studies show breakthroughs in polycythemia vera and ulcerative colitis.
Zacks Investment Research on MSN1d
PTGX Up as J&J-Partnered Drug Meets Goal in Ulcerative Colitis Study
Protagonist Therapeutics, Inc. PTGX announced positive top-line data from the phase IIb ANTHEM-UC study, which evaluated ...
Clinical Trials Arena on MSN1d
J&J and Protagonist’s icotrokinra scores in Phase IIb UC study
GlobalData predicts that icotrokinra will reach blockbuster status in 2029, with the drug forecast to generate sales of $2.19bn in 2030.
Why Is Protagonist Therapeutics Stock Trading Higher On Monday?
On Monday, Protagonist Therapeutics, Inc. PTGX announced topline results from ANTHEM-UC Phase 2b study of icotrokinra ...
BioSpace2d
J&J’s Oral IL-23R Blocker Sets New Standard in Plaque Psoriasis, Beating BMS’ Sotyktu
Late-stage data also showed that Johnson & Johnson’s icotrokinra was superior to Bristol Myers Squibb’s Sotyktu at clearing ...
Protagonist reports top line results from Phase 2b study of icotrokinra
Protagonist Therapeutics (PTGX) announced topline results from ANTHEM-UC, a Phase 2b study of icotrokinra, the first investigational targeted ...
Johnson & Johnson reports ‘positive’ results from Phase 2b study of icotrokinra
Johnson & Johnson announced positive topline results from ANTHEM-UC, a Phase 2b study of icotrokinra, the first investigational targeted ...
Health News Florida5d
A runner was hit by a car, then by a surprise $13,000 ambulance bill
A man had friends drive him to the hospital after he was hit by a car. Doctors checked him out, then sent him by ambulance to ...
USA Today6d
4 Nations Face-Off: USA fans retaliate, boo 'O Canada' ahead of hockey final
The gloves were off even earlier than that after Canadian fans loudly booed the entirety of the U.S. national anthem ahead of the American's 3-1 win at the Bell Centre in Montreal. The tournament ...